A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza a viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice

Journal of Immunology

Volumn 192, Issue 1, 2014, Pages 271-281

  Job, Emma R ^a   Bottazzi, Barbara ^b   Short, Kirsty R ^a   Deng, Yi Mo ^c   Mantovani, Alberto ^b,d   Brooks, Andrew G ^a   Reading, Patrick C ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; HEMAGGLUTININ; PENTRAXIN 3; SIALIC ACID; VIRUS SIALIDASE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG EFFECT; INFLUENZA A (H3N2); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H7N9; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RESIDUE ANALYSIS; SEQUENCE ANALYSIS; VIROGENESIS; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS VIRULENCE;

EID: 84891086682     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301814     Document Type: Article

References (67)

1. Krizanová, O., and V. Rathová. 1969. Serum inhibitors of myxoviruses. Curr. Top. Microbiol. Immunol. 47: 125-151.
2. Gottschalk, A., G. Belyavin, and F. Biddle. 1972. Glycoproteins. Their Composition, Structure and Function. Elsevier, New York.
3. Anders, E. M., C. A. Hartley, and D. C. Jackson. 1990. Bovine and mouse serum b inhibitors of influenza A viruses are mannose-binding lectins. Proc. Natl. Acad. Sci. USA 87: 4485-4489.
4. Crouch, E., K. Hartshorn, and I. Ofek. 2000. Collectins and pulmonary innate immunity. Immunol. Rev. 173: 52-65.
5. Ng, W. C., M. D. Tate, A. G. Brooks, and P. C. Reading. 2012. Soluble host defense lectins in innate immunity to influenza virus. J. Biomed. Biotechnol. 2012: 732191.
6. Hanaoka, K., T. J. Pritchett, S. Takasaki, N. Kochibe, S. Sabesan, J. C. Paulson, and A. Kobata. 1989. 4-O-acetyl-N-acetylneuraminic acid in the N-linked carbohydrate structures of equine and guinea pig alpha 2-macroglobulins, potent inhibitors of influenza virus infection. J. Biol. Chem. 264: 9842-9849.
7. Pritchett, T. J., and J. C. Paulson. 1989. Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin. J. Biol. Chem. 264: 9850-9858.
8. Benne, C. A., C. A. Kraaijeveld, J. A. van Strijp, E. Brouwer, M. Harmsen, J. Verhoef, L. M. van Golde, and J. F. van Iwaarden. 1995. Interactions of surfactant protein A with influenza A viruses: binding and neutralization. J. Infect. Dis. 171: 335-341.
9. Hartshorn, K. L., M. R. White, V. Shepherd, K. Reid, J. C. Jensenius, and E. C. Crouch. 1997. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am. J. Physiol. 273: L1156-L1166.
10. Verma, A., M. White, V. Vathipadiekal, S. Tripathi, J. Mbianda, M. Ieong, L. Qi, J. K. Taubenberger, K. Takahashi, J. C. Jensenius, et al. 2012. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses. J. Immunol. 189: 2478-2487.
11. Reading, P. C., S. Bozza, B. Gilbertson, M. Tate, S. Moretti, E. R. Job, E. C. Crouch, A. G. Brooks, L. E. Brown, B. Bottazzi, et al. 2008. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J. Immunol. 180: 3391-3398.
12. Job, E. R., B. Bottazzi, B. Gilbertson, K. M. Edenborough, L. E. Brown, A. Mantovani, A. G. Brooks, and P. C. Reading. 2013. Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses. PLoS ONE 8: e59623.
13. Bottazzi, B., A. Doni, C. Garlanda, and A. Mantovani. 2010. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu. Rev. Immunol. 28: 157-183.
14. Inforzato, A., V. Rivieccio, A. P. Morreale, A. Bastone, A. Salustri, L. Scarchilli, A. Verdoliva, S. Vincenti, G. Gallo, C. Chiapparino, et al. 2008. Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization. J. Biol. Chem. 283: 10147-10161.
15. Doni, A., G. Peri, M. Chieppa, P. Allavena, F. Pasqualini, L. Vago, L. Romani, C. Garlanda, and A. Mantovani. 2003. Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. Eur. J. Immunol. 33: 2886-2893.
16. Goodman, A. R., D. E. Levy, L. F. Reis, and J. Vilcek. 2000. Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages. J. Leukoc. Biol. 67: 387-395.
17. Han, B., M. Mura, C. F. Andrade, D. Okutani, M. Lodyga, C. C. dos Santos, S. Keshavjee, M. Matthay, and M. Liu. 2005. TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. J. Immunol. 175: 8303-8311.
18. Inforzato, A., G. Peri, A. Doni, C. Garlanda, A. Mantovani, A. Bastone, A. Carpentieri, A. Amoresano, P. Pucci, A. Roos, et al. 2006. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation. Biochemistry 45: 11540-11551.
19. Andersen, O., K. Vilsgaard Ravn, I. Juul Sørensen, G. Jonson, E. Holm Nielsen, and S. E. Svehag. 1997. Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro. Scand. J. Immunol. 46: 331-337.
20. Horváth, A., I. Andersen, K. Junker, B. Lyck Fogh-Schultz, E. Holm Nielsen, S. Gizurarson, O. Andersen, J. Kármán, E. Rajnavölgyi, A. Erdei, and S. E. Svehag. 2001. Serum amyloid P component inhibits influenza Avirus infections: in vitro and in vivo studies. Antiviral Res. 52: 43-53.
21. Dong, A., W. S. Caughey, and T. W. Du Clos. 1994. Effects of calcium, magnesium, and phosphorylcholine on secondary structures of human C-reactive protein and serum amyloid P component observed by infrared spectroscopy. J. Biol. Chem. 269: 6424-6430.
22. Bottazzi, B., V. Vouret-Craviari, A. Bastone, L. De Gioia, C. Matteucci, G. Peri, F. Spreafico, M. Pausa, C. D'Ettorre, E. Gianazza, et al. 1997. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J. Biol. Chem. 272: 32817-32823.
23. Kilbourne, E. D. 1969. Future influenza vaccines and the use of genetic recombinants. Bull. World Health Organ. 41: 643-645.
24. Anders, E. M., C. A. Hartley, P. C. Reading, and R. A. Ezekowitz. 1994. Complement-dependent neutralization of influenza virus by a serum mannosebinding lectin. J. Gen. Virol. 75: 615-622.
25. Hoffmann, E., S. Krauss, D. Perez, R. Webby, and R. G. Webster. 2002. Eightplasmid system for rapid generation of influenza virus vaccines. Vaccine 20: 3165-3170.
26. Hensley, S. E., S. R. Das, A. L. Bailey, L. M. Schmidt, H. D. Hickman, A. Jayaraman, K. Viswanathan, R. Raman, R. Sasisekharan, J. R. Bennink, and J. W. Yewdell. 2009. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326: 734-736.
27. Job, E. R., Y. M. Deng, M. D. Tate, B. Bottazzi, E. C. Crouch, M. M. Dean, A. Mantovani, A. G. Brooks, and P. C. Reading. 2010. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J. Immunol. 185: 4284-4291.
28. Tate, M. D., A. G. Brooks, and P. C. Reading. 2011. Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice. J. Immunol. 187: 1884-1894.
29. Reading, P. C., D. L. Pickett, M. D. Tate, P. G. Whitney, E. R. Job, and A. G. Brooks. 2009. Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice. Respir. Res. 10: 117.
30. Tate, M. D., Y. M. Deng, J. E. Jones, G. P. Anderson, A. G. Brooks, and P. C. Reading. 2009. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J. Immunol. 183: 7441-7450.
31. Ryan-Poirier, K., Y. Suzuki, W. J. Bean, D. Kobasa, A. Takada, T. Ito, and Y. Kawaoka. 1998. Changes in H3 influenza A virus receptor specificity during replication in humans. Virus Res. 56: 169-176.
32. Tate, M. D., A. G. Brooks, and P. C. Reading. 2011. Correlation between sialic acid expression and infection of murine macrophages by different strains of influenza virus. Microbes Infect. 13: 202-207.
33. Chen, L. M., P. Rivailler, J. Hossain, P. Carney, A. Balish, I. Perry, C. T. Davis, R. Garten, B. Shu, X. Xu, et al. 2011. Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States. Virology 412: 401-410.
34. Stevens, J., O. Blixt, T. M. Tumpey, J. K. Taubenberger, J. C. Paulson, and I. A. Wilson. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312: 404-410.
35. Chutinimitkul, S., D. van Riel, V. J. Munster, J. M. van den Brand, G. F. Rimmelzwaan, T. Kuiken, A. D. Osterhaus, R. A. Fouchier, and E. de Wit. 2010. In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J. Virol. 84: 6825-6833.
36. Kageyama, T., S. Fujisaki, E. Takashita, H. Xu, S. Yamada, Y. Uchida, G. Neumann, T. Saito, Y. Kawaoka, and M. Tashiro. 2013. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. [Published erratum appears in 2013 Euro Surveill. 18: 20459.] Euro Surveill. 18: 20453.
37. Xiong, X., S. R. Martin, L. F. Haire, S. A. Wharton, R. S. Daniels, M. S. Bennett, J. W. McCauley, P. J. Collins, P. A. Walker, J. J. Skehel, and S. J. Gamblin. 2013. Receptor binding by an H7N9 influenza virus from humans. Nature 499: 496-499.
38. Bharadwaj, D., C. Mold, E. Markham, and T. W. Du Clos. 2001. Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. J. Immunol. 166: 6735-6741.
39. Lu, J., L. L. Marnell, K. D. Marjon, C. Mold, T.W. Du Clos, and P. D. Sun. 2008. Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 456: 989-992.
40. Doni, A., C. Garlanda, B. Bottazzi, S. Meri, P. Garred, and A. Mantovani. 2012. Interactions of the humoral pattern recognition molecule PTX3 with the complement system. Immunobiology 217: 1122-1128.
41. Rogers, G. N., and J. C. Paulson. 1983. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127: 361-373.
42. Ito, T., Y. Suzuki, L. Mitnaul, A. Vines, H. Kida, and Y. Kawaoka. 1997. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 227: 493-499.
43. Wagner, R., M. Matrosovich, and H. D. Klenk. 2002. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol. 12: 159-166.
44. Grose, C., and K. Chokephaibulkit. 2004. Avian influenza virus infection of children in Vietnam and Thailand. Pediatr. Infect. Dis. J. 23: 793-794.
45. Reading, P. C., L. S. Morey, E. C. Crouch, and E. M. Anders. 1997. Collectinmediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J. Virol. 71: 8204-8212.
46. LeVine, A. M., J. A. Whitsett, K. L. Hartshorn, E. C. Crouch, and T. R. Korfhagen. 2001. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J. Immunol. 167: 5868-5873.
47. Bozza, S., F. Bistoni, R. Gaziano, L. Pitzurra, T. Zelante, P. Bonifazi, K. Perruccio, S. Bellocchio, M. Neri, A. M. Iorio, et al. 2006. Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 108: 3387-3396.
48. Han, B., X. Ma, J. Zhang, Y. Zhang, X. Bai, D. M. Hwang, S. Keshavjee, G. A. Levy, I. McGilvray, and M. Liu. 2012. Protective effects of long pentraxin PTX3 on lung injury in a severe acute respiratory syndrome model in mice. Lab. Invest. 92: 1285-1296.
49. Moalli, F., M. Paroni, T. Véliz Rodriguez, F. Riva, N. Polentarutti, B. Bottazzi, S. Valentino, S. Mantero, M. Nebuloni, A. Mantovani, et al. 2011. The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa. J. Immunol. 186: 5425-5434.
50. Gambaryan, A. S., A. B. Tuzikov, G. V. Pazynina, J. A. Desheva, N. V. Bovin, M. N. Matrosovich, and A. I. Klimov. 2008. 6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry. Virol. J. 5: 85.
51. Chandrasekaran, A., A. Srinivasan, R. Raman, K. Viswanathan, S. Raguram, T. M. Tumpey, V. Sasisekharan, and R. Sasisekharan. 2008. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat. Biotechnol. 26: 107-113.
52. Fang, R., W. Min Jou, D. Huylebroeck, R. Devos, and W. Fiers. 1981. Complete structure of A/duck/Ukraine/63 influenza hemagglutinin gene: animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin. Cell 25: 315-323.
53. Glaser, L., J. Stevens, D. Zamarin, I. A. Wilson, A. García- Sastre, T. M. Tumpey, C. F. Basler, J. K. Taubenberger, and P. Palese. 2005. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J. Virol. 79: 11533-11536.
54. Pappas, C., K. Viswanathan, A. Chandrasekaran, R. Raman, J. M. Katz, R. Sasisekharan, and T. M. Tumpey. 2010. Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957. PLoS ONE 5: e11158.
55. Matrosovich, M., A. Tuzikov, N. Bovin, A. Gambaryan, A. Klimov, M.R. Castrucci, I. Donatelli, and Y. Kawaoka. 2000. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 74: 8502-8512.
56. Wilson, I. A., J. J. Skehel, and D. C. Wiley. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289: 366-373.
57. Ryan-Poirier, K. A., and Y. Kawaoka. 1991. Distinct glycoprotein inhibitors of influenza A virus in different animal sera. J. Virol. 65: 389-395.
58. Rogers, G. N., T. J. Pritchett, J. L. Lane, and J. C. Paulson. 1983. Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants. Virology 131: 394-408.
59. Matrosovich, M., P. Gao, and Y. Kawaoka. 1998. Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host. J. Virol. 72: 6373-6380.
60. Baum, L. G., and J. C. Paulson. 1990. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem. Suppl. 40: 35-38.
61. Hartshorn, K. L., E. C. Crouch, M. R. White, P. Eggleton, A. I. Tauber, D. Chang, and K. Sastry. 1994. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J. Clin. Invest. 94: 311-319.
62. Hartshorn, K. L., R. Webby, M. R. White, T. Tecle, C. Pan, S. Boucher, R. J. Moreland, E. C. Crouch, and R. K. Scheule. 2008. Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respir. Res. 9: 65.
63. Pepys, M. B., T. W. Rademacher, S. Amatayakul-Chantler, P. Williams, G. E. Noble, W. L. Hutchinson, P. N. Hawkins, S. R. Nelson, J. R. Gallimore, J. Herbert, et al. 1994. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc. Natl. Acad. Sci. USA 91: 5602-5606.
64. Hartshorn, K. L., A. Ligtenberg, M. R. White, M. Van Eijk, M. Hartshorn, L. Pemberton, U. Holmskov, and E. Crouch. 2006. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem. J. 393: 545-553.
65. Mikerov, A. N., M. White, K. Hartshorn, G. Wang, and J. Floros. 2008. Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SPA2 variants expressed in CHO cells. Med. Microbiol. Immunol. (Berl.) 197: 9-12.
66. White, M. R., E. Crouch, M. van Eijk, M. Hartshorn, L. Pemberton, I. Tornoe, U. Holmskov, and K. L. Hartshorn. 2005. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L831-L840.
67. He, X., B. Han, and M. Liu. 2007. Long pentraxin 3 in pulmonary infection and acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L1039-L1049.